186 related articles for article (PubMed ID: 37828008)
1. DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma.
Strubel A; Münick P; Hartmann O; Chaikuad A; Dreier B; Schaefer JV; Gebel J; Osterburg C; Tuppi M; Schäfer B; Buck V; Rosenfeldt M; Knapp S; Plückthun A; Diefenbacher ME; Dötsch V
Cell Death Dis; 2023 Oct; 14(10):674. PubMed ID: 37828008
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization.
Gebel J; Luh LM; Coutandin D; Osterburg C; Löhr F; Schäfer B; Frombach AS; Sumyk M; Buchner L; Krojer T; Salah E; Mathea S; Güntert P; Knapp S; Dötsch V
Cell Death Differ; 2016 Dec; 23(12):1930-1940. PubMed ID: 27716744
[TBL] [Abstract][Full Text] [Related]
3. The dominant-negative interplay between p53, p63 and p73: A family affair.
Billant O; Léon A; Le Guellec S; Friocourt G; Blondel M; Voisset C
Oncotarget; 2016 Oct; 7(43):69549-69564. PubMed ID: 27589690
[TBL] [Abstract][Full Text] [Related]
4. Designed Ankyrin Repeat Proteins as a tool box for analyzing p63.
Strubel A; Münick P; Chaikuad A; Dreier B; Schaefer J; Gebel J; Osterburg C; Tuppi M; Schäfer B; Knapp S; Plückthun A; Dötsch V
Cell Death Differ; 2022 Dec; 29(12):2445-2458. PubMed ID: 35717504
[TBL] [Abstract][Full Text] [Related]
5. Structural evolution of p53, p63, and p73: implication for heterotetramer formation.
Joerger AC; Rajagopalan S; Natan E; Veprintsev DB; Robinson CV; Fersht AR
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17705-10. PubMed ID: 19815500
[TBL] [Abstract][Full Text] [Related]
6. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
[TBL] [Abstract][Full Text] [Related]
7. Structure and kinetic stability of the p63 tetramerization domain.
Natan E; Joerger AC
J Mol Biol; 2012 Jan; 415(3):503-13. PubMed ID: 22100306
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.
Krauskopf K; Gebel J; Kazemi S; Tuppi M; Löhr F; Schäfer B; Koch J; Güntert P; Dötsch V; Kehrloesser S
Structure; 2018 Aug; 26(8):1091-1100.e4. PubMed ID: 30099987
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):451-5. PubMed ID: 12969350
[TBL] [Abstract][Full Text] [Related]
11. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
12. The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
Levrero M; De Laurenzi V; Costanzo A; Gong J; Wang JY; Melino G
J Cell Sci; 2000 May; 113 ( Pt 10)():1661-70. PubMed ID: 10769197
[TBL] [Abstract][Full Text] [Related]
13. [Application of PLA Method for Detection of p53/p63/p73 Complexes in Situ in Tumour Cells and Tumour Tissue].
Hrabal V; Nekulová M; Nenutil R; Holčaková J; Coates PJ; Vojtěšek B
Klin Onkol; 2017; 30(Supplementum1):159-162. PubMed ID: 28471195
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.
Choi HR; Batsakis JG; Zhan F; Sturgis E; Luna MA; El-Naggar AK
Hum Pathol; 2002 Feb; 33(2):158-64. PubMed ID: 11957139
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk among p53 family members in cutaneous carcinoma.
Missero C; Antonini D
Exp Dermatol; 2014 Mar; 23(3):143-6. PubMed ID: 24417641
[TBL] [Abstract][Full Text] [Related]
16. Delineating functional mechanisms of the p53/p63/p73 family of transcription factors through identification of protein-protein interactions using interface mimicry.
Guven-Maiorov E; Sakakibara N; Ponnamperuma RM; Dong K; Matar H; King KE; Weinberg WC
Mol Carcinog; 2022 Jul; 61(7):629-642. PubMed ID: 35560453
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of the expression of p53, p63 and p73 in nasal and paranasal sinus carcinoma].
Zhang T; Jia H; Wang J; Shan Y; Luo S; Tang Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(20):919-21. PubMed ID: 19119599
[TBL] [Abstract][Full Text] [Related]
18. Structural diversity of p63 and p73 isoforms.
Osterburg C; Dötsch V
Cell Death Differ; 2022 May; 29(5):921-937. PubMed ID: 35314772
[TBL] [Abstract][Full Text] [Related]
19. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
20. Conformational stability and activity of p73 require a second helix in the tetramerization domain.
Coutandin D; Löhr F; Niesen FH; Ikeya T; Weber TA; Schäfer B; Zielonka EM; Bullock AN; Yang A; Güntert P; Knapp S; McKeon F; Ou HD; Dötsch V
Cell Death Differ; 2009 Dec; 16(12):1582-9. PubMed ID: 19763140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
